Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BLONANSERIN: 247 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
247
Total FAERS Reports
51 (20.6%)
Deaths Reported
104
Hospitalizations
247
As Primary/Secondary Suspect
12
Life-Threatening
6
Disabilities

First Report: 20070206 · Latest Report: 20250721

What Are the Most Common BLONANSERIN Side Effects?

#1 Most Reported
Somnolence
21 reports (8.5%)
#2 Most Reported
Schizophrenia
21 reports (8.5%)
#3 Most Reported
Drug ineffective
21 reports (8.5%)

All BLONANSERIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 21 8.5% 1 9
Schizophrenia 21 8.5% 0 14
Somnolence 21 8.5% 0 12
Hallucination, auditory 18 7.3% 0 6
Off label use 16 6.5% 2 6
Agitation 14 5.7% 7 3
Pneumonia aspiration 14 5.7% 5 8
Psychiatric symptom 14 5.7% 1 8
Insomnia 12 4.9% 0 4
Parkinsonism 12 4.9% 2 9
Toxicity to various agents 12 4.9% 11 2
Decreased appetite 11 4.5% 1 6
Delusion 11 4.5% 0 3
Extrapyramidal disorder 10 4.1% 1 6
Prescribed underdose 10 4.1% 0 4
Tremor 10 4.1% 0 6
Akathisia 9 3.6% 0 7
Drug abuse 9 3.6% 9 0
Hallucination 9 3.6% 0 2
Salivary hypersecretion 9 3.6% 0 3

Who Reports BLONANSERIN Side Effects? Age & Gender Data

Gender: 63.5% female, 36.5% male. Average age: 47.0 years. Most reports from: JP. View detailed demographics →

Is BLONANSERIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2007 1 0 1
2009 2 0 2
2010 2 0 0
2012 1 0 1
2013 3 0 1
2014 6 1 5
2015 9 5 4
2016 7 2 2
2017 9 3 6
2018 14 6 4
2019 12 8 1
2020 13 1 7
2021 15 1 5
2022 7 0 3
2023 10 1 7
2024 9 2 5
2025 7 2 5

View full timeline →

What Is BLONANSERIN Used For?

IndicationReports
Schizophrenia 113
Product used for unknown indication 92
Hallucination 5

BLONANSERIN vs Alternatives: Which Is Safer?

BLONANSERIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BLONANSERIN vs BOCEPREVIR BLONANSERIN vs BOCOCIZUMAB BLONANSERIN vs BONIVA BLONANSERIN vs BONVIVA BLONANSERIN vs BORAGE OIL BLONANSERIN vs BORIC ACID BLONANSERIN vs BORTEZOMIB BLONANSERIN vs BOSENTAN BLONANSERIN vs BOSENTAN\BOSENTAN

Official FDA Label for BLONANSERIN

Official prescribing information from the FDA-approved drug label.